fbpx
Reno CyberKnife Proudly Supports the Radiosurgical Research Institute

 

The Radiosurgical Research Institute (RRI), a 501c3 public charity, is the only independent medical research organization committed to improving the outcomes of cancer patients treated with radiosurgery.  Its mission is to advance radiosurgery as a cancer treatment through innovation, education, and quality research in collaboration with treatment centers around the world.   Before RRI, radiosurgical […]

 

Learn More

 

 

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

 

The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.   NCCN aims […]

 

Learn More

 

 

Debbie’s Metastatic Cancer Testimonial

 

 

Learn More

 

 

Prostate Cancer: Common Considerations When Choosing a Treatment

 

When diagnosed with prostate cancer, your doctor will suggest treatment options that may include one or a combination of treatments. Common prostate cancer treatment methods include active surveillance, surgery, external beam radiation therapy (EBRT), brachytherapy and stereotactic body radiation therapy (SBRT). When assessing your options and deciding on a treatment, it’s important to consider the various […]

 

Learn More

 

 

Men’s Health Week: Questions to Ask Your Urologist

 

If your doctor suspects you may have prostate cancer, screening or additional tests performed by a urologist may be recommended to confirm a diagnosis. If the disease is detected, patients are encouraged to educate themselves on all of the treatment options available for their specific case. Seeking a second opinion from a radiation oncologist, conducting research […]

 

Learn More

 

 

Study: Cancer Patients Prefer Care Involving Shared Decision Making

 

A recent study evaluating whether shared decision-making is associated with patient ratings for quality of care and physician communication shows the importance of patient input and participation in the treatment decision process. Researchers collected data on more than 5,300 patients with lung cancer or colon cancer and asked patients to report their role in nearly 11,000 […]

 

Learn More

 

 

Men’s Health Month: Understanding Prostate Cancer

 

June is Men’s Health Month, and an important time to understand and raise awareness for the main health problems that commonly affect men. One such health issue is prostate cancer, which develops in a man’s prostate gland. It is one of the most commonly diagnosed diseases in men. In 2015, the American Cancer Society estimates […]

 

Learn More

 

 

New Study: Smoking Worsens Prognosis in Prostate Cancer Patients

 

Researchers from Memorial Sloan Kettering Cancer Center in New York recently published results from a study that explored the impact of smoking history on prostate cancer treatment and progression. The findings indicated that smoking causes prostate cancer patients to fare worse than their non-smoking counterparts. The clinical study, published in the journal BJU International, analyzed […]

 

Learn More

 

 

Benefits of CyberKnife: Maintaining Quality of Life During Cancer Treatment

 

Whether it’s you or a loved one facing a cancer diagnosis, making a treatment decision can be an overwhelming experience. While eradicating or controlling the disease is commonly a top consideration when choosing a treatment method, other factors such as maintaining quality of life during and after treatment may also be a concern for some […]

 

Learn More

 

 

Cancer Research Month: Recent Study Finds Family History a Common Predictor of Prostate Cancer

 

The journal Prostate recently published a study showing that prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease. The study revealed that family history was just as effective at predicting disease incidence as the prostate-specific antigen (PSA) test, a common screening test […]

 

Learn More